Li Cai
Director/Board Member presso DINGDANG HEALTH TECHNOLOGY GROUP LTD.
Profilo
Li Cai is currently the Vice Chairman at Hangzhou Kangji Medical Instrument Co., Ltd., the Managing Director at TPG Capital Asia Inc, the Director at Novotech (Australia) Pty Ltd., the Director at Biosuntek Laboratory Co. Ltd., the Director at Zhejiang Choisun Tea Development Co. Ltd., the Non-Executive Director at Kangji Medical Holdings Ltd., the Director at Opc Co. Holdings Cayman Islands Ltd., the Director at Opc Intermediate Holding Co. Cayman Islands Ltd., the Director at Ppc Kk Japan Ltd., the Director at Apluscro Pte Ltd., the Director at Ppc Korea Ltd., the Director at Ppc China Corp.
Ltd., the Director at Ppc China Clinical Research Corp.
Ltd., the Director at Jiasheng Shanghai Pharmaceutical Consulting Co. Ltd., the Director at Aplus Pharmaceutical Consulting Shanghai Co. Ltd., the Director at Bailixing Xiamen Equity Investment Co. Ltd., the Director at Acrostar Pharmaservices Corp., the Director at Acrostar Site Management Co. Ltd., the Director at Novotech Holdings Pty Ltd., the Director at Novotech Aus Holdco Pty Ltd., the Non-Executive Director at Novotech Health Holdings Ltd., the Non-Executive Director at Dingdang Health Technology Group Ltd., the Director at Ppc Holding Co., the Non-Executive Director at Chongho Bridge Ltd., the Director at Novotech Laboratory Services Shanghai Co. Ltd., the Principal at TPG Capital-China Ltd., and a Member-Supervisory Board at Shanghai Deyu Deqi Enterprise Management Consulting Co. Ltd.
Ms. Cai previously worked as a Non-Executive Director at Zhaoke Ophthalmology Ltd.
from 2020 to 2023, a Non-Executive Director at Shanghai Bio-Heart Biological Technology Co., Ltd.
from 2020 to 2022, and an Investment Associate at Hao Capital Co. Ltd.
from 2009 to 2011.
Ms. Cai completed their undergraduate degree at Yale University in 2017.
Posizioni attive di Li Cai
Società | Posizione | Inizio |
---|---|---|
KANGJI MEDICAL HOLDINGS LIMITED | Director/Board Member | 13/03/2020 |
DINGDANG HEALTH TECHNOLOGY GROUP LTD. | Director/Board Member | 26/05/2021 |
TPG Capital Asia Inc
TPG Capital Asia Inc Investment ManagersFinance TPG Capital Asia Inc (TPG Asia) is a private equity subsidiary of TPG Capital Advisors LLC founded in 1992 by Richard Charles Blum, Jim Coulter, Rohit Kumar Pansalkar and David Bonderma. The firm is headquartered in Beijing, China. | Private Equity Analyst | 01/01/2011 |
Ppc Korea Ltd. | Director/Board Member | 01/08/2017 |
Ppc Holding Co. | Director/Board Member | 01/08/2017 |
Novotech Health Holdings Ltd.
Novotech Health Holdings Ltd. BiotechnologyHealth Technology Novotech Health Holdings Ltd. operates as a biotech-focused full-service contract research organization. Its integrated CRO platform provides clinical trial services ranging from consulting services prior to the commencement of the clinical phase to late-phase clinical trials. The firm’s services include: clinical trial services which include clinical research, bioequivalence and pharmacodynamics research, and drug development consulting services; and its related clinical trial services which include laboratory, site management organization, flexible insourcing and Phase I clinical trial unit services. The company was founded on February 25, 2020 and is headquartered in Singapore. | Director/Board Member | 02/12/2020 |
Novotech Aus Holdco Pty Ltd. | Director/Board Member | 01/07/2020 |
Novotech Holdings Pty Ltd.
Novotech Holdings Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Novotech Health Holdings engages in the development of contract research organization platform. The company was founded on October 12, 2020 and is headquartered in Australia. | Director/Board Member | 01/07/2020 |
Acrostar Site Management Co. Ltd. | Director/Board Member | 01/01/2019 |
░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Precedenti posizioni note di Li Cai
Società | Posizione | Fine |
---|---|---|
░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Li Cai
Yale University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
ZHAOKE OPHTHALMOLOGY LIMITED | Health Technology |
KANGJI MEDICAL HOLDINGS LIMITED | Health Technology |
SHANGHAI BIO-HEART BIOLOGICAL TECHNOLOGY CO., LTD. | Commercial Services |
DINGDANG HEALTH TECHNOLOGY GROUP LTD. | Technology Services |
Aziende private | 24 |
---|---|
TPG Capital Asia Inc
TPG Capital Asia Inc Investment ManagersFinance TPG Capital Asia Inc (TPG Asia) is a private equity subsidiary of TPG Capital Advisors LLC founded in 1992 by Richard Charles Blum, Jim Coulter, Rohit Kumar Pansalkar and David Bonderma. The firm is headquartered in Beijing, China. | Finance |
Novotech (Australia) Pty Ltd.
Novotech (Australia) Pty Ltd. BiotechnologyHealth Technology Novotech (Australia) Pty Ltd. operates as a contract research organization. It provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services and central lab services. The firm offers patient recruitment and site selection, clinical operations and project management, medical and regulatory consulting, biometrics and data management solutions. The company was founded by Alek Safarian in 1996 and is headquartered in Sydney, Australia. | Health Technology |
Hao Capital Co. Ltd. | Finance |
Biosuntek Laboratory Co. Ltd.
Biosuntek Laboratory Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Biosuntek Laboratory Co. Ltd. is a South Korean company that specializes in testing and analysis services. The private company is based in Seongnam, South Korea. | Commercial Services |
TPG Capital-China Ltd.
TPG Capital-China Ltd. Financial ConglomeratesFinance Part of TPG, Inc., TPG Capital-China Ltd. provides investment services. The private company is based in Beijing, China. | Finance |
Hangzhou Kangji Medical Instrument Co., Ltd.
Hangzhou Kangji Medical Instrument Co., Ltd. Medical DistributorsDistribution Services Hangzhou Kangji Medical Instrument Co., Ltd. manufactures and distributes medical equipment and related accessories. Its business includes reusable and disposable instruments for laparoscopy, gynecology, urology, gastroenterology, and ENT specialties. The company was founded on August 24, 2004 and is headquartered in Hangzhou, China. | Distribution Services |
Zhejiang Choisun Tea Development Co. Ltd. | |
Shanghai Deyu Deqi Enterprise Management Consulting Co. Ltd. | |
Opc Co. Holdings Cayman Islands Ltd. | |
Opc Intermediate Holding Co. Cayman Islands Ltd. | |
Ppc Kk Japan Ltd. | |
Apluscro Pte Ltd. | |
Ppc Korea Ltd. | |
Ppc China Corp. Ltd.
Ppc China Corp. Ltd. Miscellaneous Commercial ServicesCommercial Services Ppc China Corp. Ltd. operates as a contract research organization. The private company is based in Beijing, China. | Commercial Services |
Ppc China Clinical Research Corp. Ltd. | |
Jiasheng Shanghai Pharmaceutical Consulting Co. Ltd. | |
Aplus Pharmaceutical Consulting Shanghai Co. Ltd. | |
Bailixing Xiamen Equity Investment Co. Ltd. | |
Acrostar Pharmaservices Corp. | |
Acrostar Site Management Co. Ltd. | |
Novotech Holdings Pty Ltd.
Novotech Holdings Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Novotech Health Holdings engages in the development of contract research organization platform. The company was founded on October 12, 2020 and is headquartered in Australia. | Commercial Services |
Novotech Aus Holdco Pty Ltd. | |
Novotech Health Holdings Ltd.
Novotech Health Holdings Ltd. BiotechnologyHealth Technology Novotech Health Holdings Ltd. operates as a biotech-focused full-service contract research organization. Its integrated CRO platform provides clinical trial services ranging from consulting services prior to the commencement of the clinical phase to late-phase clinical trials. The firm’s services include: clinical trial services which include clinical research, bioequivalence and pharmacodynamics research, and drug development consulting services; and its related clinical trial services which include laboratory, site management organization, flexible insourcing and Phase I clinical trial unit services. The company was founded on February 25, 2020 and is headquartered in Singapore. | Health Technology |
Ppc Holding Co. |
- Borsa valori
- Insiders
- Li Cai